5-Bromo-4-methyl-1H-indole, 95.0%, 500mg

(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-acetylphenyl)propanoic acid, 98%, 250mg

2-Bromo-1-(3-chloro-4-fluorophenyl)ethanone, 95.0%, 5g

2,5-Difluorobenzyl Alcohol>98.0%(GC)5g

4-(3-Bromo-phenyl)-1-N-Boc-piperidine, 97.0%, 5g

N-Cyclopentyl-3-methyl-2,3-dihydro-1H-inden-1-amine, 97%, 100mg

4-Bromo-3,5-difluorobenzaldehyde, 97.0%, 5g

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carboxaldehyde>98.0%(GC)(T)5g

Methyl 2-Amino-5-bromo-4-chlorobenzoate, 95.0%, 5g

GC capillary column ROTI®Cap-FFAP, 30 m, 0.32 mm, 0.25 µm, 1 Piece(s)

Allolactose>98.0%(HPLC)100mg

(2E)-3-(2-fluorophenyl)-1-(4-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g